Your email has been successfully added to our mailing list.

×
0.0434782608695651 0.0434782608695651 0.0434782608695651 0.0559006211180123 0.0559006211180123 0.0559006211180123 0.0124223602484472 -0.0124223602484472
Stock impact report

ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study

ASLAN Pharmaceuticals Limited - American Depositary Shares (ASLN) 
US:NASDAQ Investor Relations: ir.aslanpharma.com
Company Research Source: GlobeNewswire
SINGAPORE, Aug. 24, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the resumption of patient recruitment into its randomised, double-blind, placebo-controlled multiple ascending dose (MAD) study of ASLAN004 in moderate to severe atopic dermatitis. ASLAN paused recruitment of new patients on 13 April 2020 in line with government restrictions enforced in Singapore to contain the spread of the coronavirus disease (COVID-19). Patients are now being recruited into the second of three dose cohorts at all screening sites in Singapore. To accelerate recruitment, ASLAN is in the process of opening additional study sites in Australia and the US. ASLAN expects to report interim, unblinded data from all 3 dose cohorts in 4Q 2020. Media and IR contacts Emma ThompsonSpurwing CommunicationsTel: +65 6751 2 Show less Read more
Impact Snapshot
Event Time:
ASLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ASLN alerts

from News Quantified
Opt-in for
ASLN alerts

from News Quantified